Get the Stockscreener App
1.00
1.96%
-0.02
Pharmacyte Biotech Inc stock is traded at $1.00, with a volume of 6,227.
It is down -1.96% in the last 24 hours and down -12.28% over the past month.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.
See More
Previous Close:
$1.02
Open:
$1.02
24h Volume:
6,227
Relative Volume:
0.44
Market Cap:
$6.86M
Revenue:
-
Net Income/Loss:
$22.68M
P/E Ratio:
1.8868
EPS:
0.53
Net Cash Flow:
$-1.94M
1W Performance:
+4.71%
1M Performance:
-12.28%
6M Performance:
-37.69%
1Y Performance:
-49.75%
1-Day Range:
$1.00
$1.02
1-Week Range:
$1.00
$1.05
52-Week Range:
$0.95
$2.4229
Pharmacyte Biotech Inc Stock (PMCB) Company Profile
Name
Pharmacyte Biotech Inc
Sector
Industry
Phone
(917) 595.2850
Address
23046 AVENIDA DE LA CARLOTA, SUITE 600, LAGUNA HILLS
Compare PMCB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| 2.24 | 0 | 0 | 0 | 0 | 0.00 | |
MOBBW
Mobilicom Limited Warrants
|
0.65 | 833.82M | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
20.31 | 372.90M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
2.82 | 120.57M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.152 | 320.01M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
DAVEW
Dave Inc
|
1.63 | 0 | 0 | 0 | 0 | 0.00 |
Pharmacyte Biotech Inc Stock (PMCB) Latest News
Why PharmaCyte Biotech Inc. stock attracts strong analyst attentionFree Entry Plan for Oversold Reversal Stocks - Newser
Analyzing recovery setups for PharmaCyte Biotech Inc. investorsPrice Spike Prediction for Active Traders - Newser
Using RSI to spot recovery in PharmaCyte Biotech Inc.In-Depth Stock Trading Volume Analysis - Newser
How sentiment analysis helps forecast PharmaCyte Biotech Inc.Predictable Return Strategy with AI Support - Newser
When is PharmaCyte Biotech Inc. stock expected to show significant growthEarnings Report Guidance For Smart Trading - jammulinksnews.com
Has PharmaCyte Biotech Inc. found a price floorLow Exposure Strategy with Sector Analysis - Newser
What makes PharmaCyte Biotech Inc. stock attractive to long term investorsFree Community Verified Stock Suggestions - Newser
What are the latest earnings results for PharmaCyte Biotech Inc.Breakout Stocks Picks For Every Investor - jammulinksnews.com
How PharmaCyte Biotech Inc. stock performs during market volatilityFree Reliable Chart-Based Trade Entries - Newser
What institutional investors are buying PharmaCyte Biotech Inc. stockBest Dividend Review For Consistent Profits - jammulinksnews.com
What machine learning models say about PharmaCyte Biotech Inc.Buy and Hold Strategy for Capital Safety - Newser
PharmaCyte Biotech Delays Yearly Report Filing - TipRanks
Can momentum traders help lift PharmaCyte Biotech Inc.Buy Zone Strategy with Pattern Recognition - Newser
PharmaCyte Biotech Inc. Included in Top Momentum ScanLow Risk High Return Opportunities Identified - metal.it
Technical Heatmap Flags PharmaCyte Biotech Inc. for WatchAI Driven Buy Alert Trade Blueprint Released - metal.it
How high can PharmaCyte Biotech Inc. stock price go in 2025Low Drawdown Stock Screener with Analysis - Newser
Momentum Traders Eye PharmaCyte Biotech Inc. for Quick BounceChart-Based Trade Entries Gain Analyst Support - metal.it
What catalysts could drive PharmaCyte Biotech Inc. stock higher in 2025Invest confidently with professional market insights - jammulinksnews.com
What are the technical indicators suggesting about PharmaCyte Biotech Inc.Invest smarter with daily stock recommendations - jammulinksnews.com
Is PharmaCyte Biotech Inc. stock overvalued or undervaluedInvest smarter with daily market updates - jammulinksnews.com
Is PharmaCyte Biotech Inc. a growth stock or a value stockBuild wealth steadily with smart trading - jammulinksnews.com
Should I hold or sell PharmaCyte Biotech Inc. stock in 2025Explosive market performance - jammulinksnews.com
How many analysts rate PharmaCyte Biotech Inc. as a “Buy”Breakthrough capital growth - jammulinksnews.com
What is the dividend policy of PharmaCyte Biotech Inc. stockAchieve rapid capital gains with smart investing - jammulinksnews.com
PharmaCyte Biotech (OTCMKTS:PMCBD) Trading Up 1% – Here’s Why - Defense World
PharmaCyte Biotech Inc. Stock Analysis and ForecastUnrivaled growth potential - PrintWeekIndia
Pharmacyte Biotech Inc Stock (PMCB) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):